Bristol-Myers Squibb Co. (BMY)
Health Care ยท Pharmaceutical Preparations
Bristol-Myers Squibb Co. (BMY) is listed on the New York Stock Exchange, where its shares have traded since June 23, 1952. SentiSense covers Bristol-Myers Squibb Co. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Chris Boerner is its chief executive officer. The company reports 32,500 employees, and its corporate website is www.bms.com.
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Latest reported results
Bristol Myers Squibb Company reported revenue of $13.07 billion for Q3 FY2026, up 6.9% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 2,492 institutions reported holding BMY, with 1.7 billion shares worth $95.9 billion in aggregate. The largest reported holders were Vanguard, BlackRock and State Street. Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter.
More on BMY
- BMY sentiment: whether news and social coverage of Bristol-Myers Squibb Co. leans bullish or bearish, and the stories driving it.
- BMY ownership: all 2,492 reporting institutions, plus insider and congressional trades.
- BMY financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Bristol-Myers Squibb Co.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Bristol-Myers Squibb Co. do?
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders.
What sector is BMY in?
SentiSense classifies Bristol-Myers Squibb Co. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does BMY stock trade?
Bristol-Myers Squibb Co. (BMY) is listed on the New York Stock Exchange, where its shares have traded since June 23, 1952.
Who is the CEO of Bristol-Myers Squibb Co.?
Chris Boerner is the chief executive officer of Bristol-Myers Squibb Co..